Related Experiment Video
Updated: Aug 15, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Cardiovascular involvement in Kawasaki disease
S Noel Narayanan1, M Zulfikar Ahamed, M Safia
1Department of Pediatrics and Cardiology, SAT Hospital, Medical College, Thiruvananthapuram 695 011, India. noeln@asianetindia.com
Insights
Early treatment with IV gammaglobulin for Kawasaki disease prevents coronary artery issues. Prompt treatment in children with Kawasaki disease significantly reduces the risk of developing long-term cardiac complications like coronary artery disease.
Area of Science:
- Pediatrics
- Cardiology
- Rheumatology
Background:
- Kawasaki disease is a significant cause of acquired heart disease in children.
- Cardiac involvement, including pancarditis and coronary artery abnormalities, is a major concern.
Purpose of the Study:
- To evaluate cardiac involvement in children with Kawasaki disease.
- To assess the long-term outcomes of coronary artery disease in affected children.
- To determine the efficacy of intravenous immunoglobulin (IVIG) in preventing cardiac complications.
Main Methods:
- Retrospective analysis of 72 patients diagnosed with Kawasaki disease over a 7-year period.
- Cardiac assessment including echocardiography to detect pancarditis and coronary artery abnormalities.
- Follow-up evaluation of coronary artery status and treatment outcomes.
Main Results:
- 28% of patients experienced mild pancarditis, which resolved.
- 18.5% developed coronary artery disease; 10 cases resolved within 1-2 years, while 3 had persistent dilatation/aneurysm.
- Children receiving IV gammaglobulin within 10 days of illness onset showed no coronary artery disease during follow-up.
Conclusions:
- Early administration of IV gammaglobulin is crucial for preventing coronary artery disease in Kawasaki disease.
- Prompt treatment significantly reduces the incidence and severity of cardiac complications.
- Long-term surveillance is important for children with persistent coronary artery abnormalities.
Abstract:
We report 72 patients with Kawasaki disease seen at this Centre over 7 years. Cardiac involvement in the form of mild pancarditis was seen in 28 % patients, but disappeared subsequently. Thirteen (18.5 percent) children developed coronary artery disease, out of which 4 resolved by the end of two months and another 6 after one year; 3 patients continued to show coronary artery dilatation and aneurysm formation. Children who received IV gammaglobulin in full dose within 10 days of onset of illness, showed no evidence of coronary artery disease during follow up.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
